Short answer? For most people, no. Wegovy works better for weight loss, costs about the same or less once you factor in Novo Nordisk’s own cash pricing, and Saxenda is actually being phased out. If you’re picking between Saxenda vs Wegovy today, Wegovy is the safer long-term choice for almost everyone. There’s one small group where Saxenda still makes sense, and we’ll get to that.
Quick verdict box
Skip Saxenda if: you want the best shot at losing weight, you don’t want to deal with a daily shot, or you care about a medicine that will still be around in two years.
Saxenda might still work for you if you’re already stable on it, your insurance covers it at a low cost, and switching would mess with a plan that’s working. Even then, you’ll need a backup plan soon.
Pick Wegovy if: you want a once-weekly shot with stronger average weight loss and a drug that isn’t going away.
Price: Saxenda’s list price on NovoCare is around $1,350 a month. Wegovy’s list price is also around $1,350 per month, but Novo Nordisk sells Wegovy directly to self-pay patients for much less, starting at $349 per month for the pen (more on that below).
Saxenda vs Wegovy: what’s actually different
Both are made by Novo Nordisk. Both help with weight loss. But they’re not twins.
Saxenda is liraglutide. It’s a daily shot. It was the first big GLP-1 approved for weight loss, back in 2014, and it’s kind of the granddad of this whole category now.
Wegovy is semaglutide. It’s a once-weekly shot (there’s also a pill version now), and in head-to-head style data it tends to produce more weight loss than liraglutide. That’s the main reason a lot of doctors have moved patients off Saxenda and onto Wegovy or Zepbound over the past few years.
And here’s the part that really matters for anyone asking “is Saxenda still worth it”: Novo Nordisk is discontinuing it. Their physician-facing site says the last shipments to wholesalers happen in late January 2027, because fewer people are using it now that newer options exist. It’s not a safety pull. It’s just Novo Nordisk trimming the lineup. But it means starting Saxenda now is starting a countdown clock on a medicine you’ll eventually have to switch off of anyway.
Saxenda review
What it is: liraglutide, a daily injectable GLP-1 for chronic weight management in adults, and for teens 12 to 17 who are above a certain weight with obesity.
Price, per NovoCare: list price is around $1,350 a month. If you have commercial insurance and qualify for the manufacturer savings card, you can pay as little as $25, or save up to $200 per prescription, for up to 12 months. That’s a big gap between list price and what most insured people actually pay.
If you don’t have insurance, you’re mostly stuck near that $1,349 number unless you use a discount card, and even then you’re usually still paying somewhere in the $370 to $1,200 range depending on the pharmacy and coupon.
How signup works: you need a prescription, so this usually starts with your doctor or a telehealth visit. NovoCare’s site walks you through checking coverage before you fill it.
Insurance: coverage is honestly a mixed bag. It’s more consistent when it’s prescribed for diabetes management. For pure weight loss, a lot of plans want prior authorization first, and some just won’t cover it at all.
Cancelling: since it’s a regular prescription, not a subscription, you cancel by simply not refilling it and telling your doctor you’re stopping. No monthly membership to cancel.
Common complaints: nausea is the big one, especially in the first few weeks. Also injection site reactions and, for some people, less weight loss than they hoped for compared to what they’d read about the newer drugs.
Who should skip it: honestly, most new patients. If you’re just starting a GLP-1 in 2026, starting on a drug that’s being discontinued within the next year or so is kind of a rough plan. Gonna be honest here, it doesn’t make a ton of sense unless cost or coverage forces your hand.
Who it might still work for: people who are already on Saxenda, tolerating it well, and paying close to that $25 savings card price. Even then, talk to your doctor now about a switch plan before the discontinuation actually hits your pharmacy.
Wegovy review
What it is: semaglutide, approved for chronic weight management in adults and teens, plus it now carries approvals for reducing cardiovascular risk in adults with heart disease and for NASH liver disease in certain patients. It comes as a weekly pen and, as of 2026, also as a daily pill.
Price, per NovoCare and Wegovy’s official site: list price is around $1,350 a month, same number as Saxenda. But Novo Nordisk runs its own self-pay pharmacy, NovoCare Pharmacy, and that’s where the real number lives for people paying cash. As of today, the standard pen price through NovoCare Pharmacy is $349 a month for the 0.25 mg through 2.4 mg doses, and $399 a month for the higher strength HD 7.2 mg pen. New patients starting on the 0.25 mg or 0.5 mg starter doses get an introductory price of $199 a month for their first two fills, and that offer currently runs through December 31, 2026.
The pill is cheaper still. NovoCare lists it at $149 a month for the 1.5 mg and 4 mg doses (the 4 mg price holds through August 31, 2026, then moves to $199), and $299 a month for the 9 mg and 25 mg doses.
If you’ve got commercial insurance that covers Wegovy, the manufacturer savings offer can bring your cost down to as little as $25 a month, capped at a certain savings amount. If you’re on Medicare, GLP-1 coverage rules have been changing, and any cost-sharing programme you read about is worth confirming directly on Medicare.gov or with your Part D plan before you count on it.
How signup works: same as Saxenda; you need a prescription first. Then you either fill it at a regular pharmacy, use the savings offer, or order direct through NovoCare Pharmacy for home delivery.
Insurance: better odds of coverage than Saxenda for weight loss, especially now that it also has a cardiovascular risk reduction approval, which some plans treat differently than a pure weight loss claim. Prior authorization is still common though.
Cancelling: no subscription lock-in on the drug itself. Stop refilling, and you’re done. If you’re on NovoCare Pharmacy’s home delivery, you just stop reordering.
Common complaints: nausea, constipation, and fatigue are the most reported, especially while your dose is going up. Some people also mention the cost jump if they lose insurance coverage partway through treatment.
Who should skip it: if you have a personal or family history of medullary thyroid cancer or MEN 2, this isn’t for you, full stop. Talk to your doctor about other options. People who can’t tolerate GI side effects at all might also want to look at other paths first.
Who it’s for: most people starting a GLP-1 for weight loss in 2026 who want a drug backed by strong Novo Nordisk investment and pricing support, not one that’s on its way out.
Saxenda vs Wegovy price and plan comparison
| List price | around $1,350/month | around $1,350/month |
| Cash self pay (NovoCare) | Not offered through NovoCare Pharmacy | $349/month pen (standard), $199/month intro for starters, $149 to $299/month pill |
| Insured savings card | As low as $25, up to $200 off, 12 months | As low as $25, capped savings, eligibility varies |
| Dosing | Daily injection | Weekly injection or daily pill |
| Future availability | Being discontinued, last shipments late January 2027 | Actively supported and expanding (new pill form, new approvals) |
Pick Saxenda if: you’re already on it, it’s working, and your insurance makes it cheap. Otherwise, hold on, is it really worth starting something that’s getting pulled from shelves soon? Probably not.
Pick Wegovy if: you’re starting fresh, want stronger average results, and want a drug Novo Nordisk is clearly sticking with long-term.
FAQ
Is Saxenda being discontinued? Yes. Novo Nordisk’s own site for prescribers says the last shipments to wholesalers happen in late January 2027. It’s a business decision, not a safety recall.
Is Wegovy stronger than Saxenda? In general, semaglutide (Wegovy) tends to produce more weight loss on average than liraglutide (Saxenda) in the studies used for FDA approval. Ask your doctor about the specific trial data for your situation.
Which one is cheaper without insurance? Wegovy, by a wide margin, once you use Novo Nordisk’s own NovoCare Pharmacy self-pay pricing. Saxenda doesn’t have a comparable cash program on NovoCare’s site right now.
Can I switch from Saxenda to Wegovy? Many people do, especially now that Saxenda is being phased out. This needs to go through your doctor, since dosing and titration are different between the two.
Does insurance cover either one? Sometimes, and it depends heavily on your specific plan and whether the prescription is for diabetes, weight loss, or (for Wegovy) cardiovascular risk reduction. Check your coverage directly before assuming either way.
My honest take
I’d skip Saxenda at this point, and not because it’s a bad drug. It did its job for a lot of people for over a decade. It’s just getting phased out, and starting a new prescription on something with an expiration date on the whole product line feels like setting yourself up for a switch you didn’t ask for. Wegovy costs about the same at list price, but Novo Nordisk’s own cash pricing makes it a lot more affordable in practice, and it’s the drug they’re clearly building around going forward. Talk with your doctor about which one fits your health history, but if you’re starting from zero today, Wegovy is where I’d point you.